Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
2 hedge funds and large institutions have $55.7K invested in Global Cord Blood Corporation in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
67% less funds holding
Funds holding: 6 → 2 (-4)
80% less capital invested
Capital invested by funds: $275K → $55.7K (-$220K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Natixis Advisors
Boston,
Massachusetts
|
-$211K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$12.9K |
| 3 |
UB
UMB Bank
Kansas City,
Missouri
|
-$4.18K |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
-$158 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
RhumbLine Advisers
Boston,
Massachusetts
| $55.5K | – | – | – |
|
|
OA
2
Operose Advisors
Milwaukee,
Wisconsin
| $248 | – | – | – |
|
|
3
Natixis Advisors
Boston,
Massachusetts
| – | -$211K | -200,914 | Closed |
|
|
4
Marshall Wace
London,
United Kingdom
| – | -$12.9K | -12,332 | Closed |
|
|
UB
5
UMB Bank
Kansas City,
Missouri
| – | -$4.18K | -3,978 | Closed |
|
|
SPIA
6
Steward Partners Investment Advisory
New York
| – | -$158 | -150 | Closed |
|
CO Hedge Fund Activity: Q3 2023 in Review
2 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2023, worth a combined $55.7K — down 80% from $275K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CO and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Natixis Advisors, exiting entirely with an estimated $211K sold.
- 2 institutional investors held Global Cord Blood Corporation (CO) as of Q3 2023, down from 6 in Q2 2023.
- Funds reported $55.7K of Global Cord Blood Corporation stock for Q3 2023, down 80% quarter-over-quarter.
- 0 funds opened new Global Cord Blood Corporation positions in Q3 2023 and 4 closed out, a net change of -4 holders.
- The largest Global Cord Blood Corporation seller in Q3 2023 was Natixis Advisors, an estimated $211K sold.
Based on aggregated 13F filings for Q3 2023.